AI breast cancer diagnosis technology approved for UK and EU

The breast cancer diagnosis technology – called PANProfiler – has been developed by Panakeia and can accurately predict biomarker status from digitally imaged routine pathology samples. The technology has received UKCA and CE certification for clinical use by health services in the UK and EU. Read more

Panakeia PANProfiler Breast receives CE mark

A new AI-based test that can predict the most effective treatment from images of routine cancer samples has been approved for use in the UK and EU, speeding up diagnosis and reducing the need for lab testing. Read more

Revealing UK’s MedTech 50 and HealthTech 50 for 2021

Panakeia was short-listed among the first three of 50 innovative medTech companies in the UK. See more